Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H12O6 |
Molecular Weight | 300.2629 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2
InChI
InChIKey=SQFSKOYWJBQGKQ-UHFFFAOYSA-N
InChI=1S/C16H12O6/c1-21-10-4-2-8(3-5-10)16-15(20)14(19)13-11(18)6-9(17)7-12(13)22-16/h2-7,17-18,20H,1H3
Kaempferide (3,5,7-trihydroxy-4′-methoxyflavone,
Kae) is a naturally occurring flavonoid that is
isolated from the roots of Alpinia officinarum (lesser galangal). Like other flavonoids, Kae also has a very good
antioxidant properties and Kae can effectively reduce 1,1-
diphenyl-2-picrylhydrazyl (DPPH). Studies have shown
that Kae has anticancer and antihypertension effects. Kaempferide protects against myocardial Ischemia/reperfusion Injury through activation of the PI3K/Akt/GSK-3β pathway. Kaempferide inhibited potent antioxidant activity. Kaempferide is one of the candidates for active compound in propolis. Kaempferide, the most active among the four flavonoids isolated and characterized from Chromolaena odorata, induces apoptosis in cervical cancer cells while being pharmacologically safe.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P0AGJ9 Gene ID: 948855.0 Gene Symbol: tyrS Target Organism: Escherichia coli (strain K12) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27487455 |
|||
Target ID: CHEMBL3551 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25580686 |
|||
Target ID: WP408 |
|||
Target ID: CHEMBL4261 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21865046 |
|||
Target ID: CHEMBL5346 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19615910 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Inhibitory activity of flavonoids and tannins against HIV-1 protease. | 2000 Sep |
|
Kaempferide triglycoside: a possible factor of resistance of carnation (Dianthus caryophyllus) to Fusarium oxysporum f. sp. dianthi. | 2001 Apr |
|
Phenolic compounds of propolis from Central Chilean matorral. | 2001 Mar-Apr |
|
Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. | 2002 Feb |
|
Flavonol glycosides of Warburgia ugandensis leaves. | 2003 Oct |
|
Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. | 2004 Sep |
|
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. | 2005 Oct 4 |
|
Flavonoids from Echinops echinatus. | 2006 Apr-May |
|
In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide. | 2006 Jan |
|
Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. | 2007 Nov |
|
[Studies on chemical constituents of Salacia prinoides]. | 2008 Sep |
|
Brazilian propolis: correlation between chemical composition and antimicrobial activity. | 2008 Sep |
|
Chemical composition and botanical origin of red propolis, a new type of brazilian propolis. | 2008 Sep |
|
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells. | 2009 Aug 15 |
|
From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. | 2009 Jul 22 |
|
Reversing β-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime. | 2010 Dec 15 |
|
Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes. | 2010 Jan 1 |
|
Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy. | 2012 Jun |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28928604
Rats were randomly divided into
7 groups: (1) sham group, rats underwent sham surgery;
(2) I/R group, rats were subjected to a 30 min LAD coronary
artery ligation followed by a 2 h reperfusion; (3) L-Kae (Kaempferide) + I/R
group, rats were injected with a low dose of Kae (L-Kae;
0.1 mg/kg body weight) 30 min prior to I/R, then subjected
to a 30 min LAD coronary artery ligation followed by a 2 h
reperfusion; (4) M-Kae + I/R group, rats were injected with
a moderate dose of Kae (M-Kae; 0.3 mg/kg body weight)
30 min prior to I/R, then subjected to a 30 min LAD coronary
artery ligation followed by a 2 h reperfusion; (5) H-Kae + I/R
group, rats were injected with a high dose of Kae (H-Kae;
1 mg/kg body weight) 30 min prior to I/R, then subjected to
a 30 min LAD coronary artery ligation followed by a 2 h
reperfusion;
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19615910
Kaempferide inhibited melanogenesis (81.2% inhibition) in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
58925
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
491-54-3
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
207-738-4
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
6099
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
KAEMPFERIDE
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
5281666
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
508XL61MPD
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
407294
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY | |||
|
DTXSID9034155
Created by
admin on Fri Dec 15 19:13:40 GMT 2023 , Edited by admin on Fri Dec 15 19:13:40 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD